Royalty Pharma
RPRX
#1213
Rank
A$23.45 B
Marketcap
$39.80
Share price
-1.17%
Change (1 day)
-7.69%
Change (1 year)

Earnings for Royalty Pharma (RPRX)

Earnings in 2024 (TTM): A$1.80 Billion

According to Royalty Pharma's latest financial reports the company's current earnings are A$2.23 Billion. In 2023 the company made an earning of A$2.86 Billion, an increase over its 2022 earnings that were of A$0.63 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Royalty Pharma from 2019 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$1.80 B-36.88%
2023 A$2.86 B351.47%
2022 A$0.63 B-70.3%
2021 A$2.13 B-24.3%
2020 A$2.82 B-31.9%
2019 A$4.14 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$53.91 M-97.08%๐Ÿ‡บ๐Ÿ‡ธ USA
A$10.29 B 457.26%๐Ÿ‡บ๐Ÿ‡ธ USA
A$15.41 B 734.54%๐Ÿ‡บ๐Ÿ‡ธ USA